Related Experiment Video
Updated: Jul 4, 2026

08:25
Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
Published on: September 26, 2022
T regulatory cells in contact hypersensitivity
1Laboratory of Immunology, IDI-IRCCS, Rome, Italy. cavani@idi.it
Current Opinion in Allergy and Clinical Immunology
|July 4, 2008
Summary
Regulatory T cells are key to preventing skin reactions to chemicals. Expanding these cells offers a potential cure for contact hypersensitivity, a common immune disorder.
Area of Science:
- Immunology
- Dermatology
- Allergy and Hypersensitivity
Background:
- Contact hypersensitivity involves immune responses to small chemicals (haptens) that penetrate the skin.
- Regulatory T cells (Tregs) are crucial for maintaining immune tolerance to environmental antigens.
- Understanding Treg mechanisms is vital for managing skin allergies.
Purpose of the Study:
- To review recent research on the role of T regulatory cells in hapten-induced diseases.
- To explore the mechanisms by which Tregs control immune responses to haptens.
- To evaluate the therapeutic potential of Tregs in treating contact hypersensitivity.
Main Methods:
- Literature review of recent investigations on T regulatory cells and hapten diseases.
- Analysis of studies detailing Treg subsets (e.g., CD4+ Tregs) and their suppressive functions.
- Examination of research on IL-10 release and direct cell-cell interactions in Treg-mediated suppression.
Main Results:
- Specific T regulatory cells, predominantly CD4+ Tregs, are essential for tolerance to skin-penetrating chemicals.
- Tregs suppress hapten-specific immune responses via IL-10 secretion and direct inhibition of effector T cells.
- These mechanisms prevent harmful immune reactions to environmental antigens.
Conclusions:
- In vitro and in vivo expansion of antigen-specific T regulatory cells shows promise for treating contact hypersensitivity.
- Targeting Treg expansion could offer an innovative therapeutic strategy for allergic skin conditions.
- Further research into Treg-based therapies is warranted for immune-mediated skin diseases.
Related Concept Videos
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
